Cyberjaya University College of Medical Sciences Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2019
NCT03816618
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cyberjaya University College of Medical Sciences | Diabetic Center-KFSH

Active Ingredients

Drugs in Phase 1 Trials (2)

fusidic acid (Fucidin) (1 trial)

leptospermum honey (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2